Early pharmacologic treatment in Parkinson's disease.
Hauser
Robert A
RA
USF Health-Movement Disorders Center, 5 Tampa General Circle, Harbourside Medical Tower, Tampa, FL 33606, USA. rhauser@health.usf.edu
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use; D042241:Early Diagnosis; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000188:drug therapy*; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D008996:Monoamine Oxidase Inhibitors; D014451:Ubiquinone; D014810:Vitamin E; D007980:Levodopa; C024989:coenzyme Q10